secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2026-05-15T20:10:34+00:00
Accession:  0001104659-26-062536
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte
--------------------------------------------------------------------------------

- All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.
- Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.
- Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.
- Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/tm2614189d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-062536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer